CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Open-market sale SVP & Chief Medical Officer sold 4,760 shares at $4.65 ($22,152)
- 4/A Open-market buy President and CEO bought 10,000 shares at an average $5.35 ($53,465)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 17 of 29 · 579 filings